FI910973A0 - Antikropp mot tumornekrosfaktorreseptor. - Google Patents

Antikropp mot tumornekrosfaktorreseptor.

Info

Publication number
FI910973A0
FI910973A0 FI910973A FI910973A FI910973A0 FI 910973 A0 FI910973 A0 FI 910973A0 FI 910973 A FI910973 A FI 910973A FI 910973 A FI910973 A FI 910973A FI 910973 A0 FI910973 A0 FI 910973A0
Authority
FI
Finland
Prior art keywords
necrosfactor
antikropp
receptor
mot tumor
mot
Prior art date
Application number
FI910973A
Other languages
English (en)
Other versions
FI910973A (fi
Inventor
Klaus Pfizenmaier
Peter Scheurich
Bettina Thoma
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of FI910973A0 publication Critical patent/FI910973A0/fi
Publication of FI910973A publication Critical patent/FI910973A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI910973A 1990-02-28 1991-02-27 Antikropp mot tumornekrosfaktorreseptor. FI910973A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4006269A DE4006269A1 (de) 1990-02-28 1990-02-28 Antikoerper gegen den tumor-nekrosefaktor-rezeptor

Publications (2)

Publication Number Publication Date
FI910973A0 true FI910973A0 (fi) 1991-02-27
FI910973A FI910973A (fi) 1991-08-29

Family

ID=6401127

Family Applications (1)

Application Number Title Priority Date Filing Date
FI910973A FI910973A (fi) 1990-02-28 1991-02-27 Antikropp mot tumornekrosfaktorreseptor.

Country Status (6)

Country Link
US (1) US5736138A (fi)
EP (1) EP0444560A1 (fi)
JP (1) JPH04211392A (fi)
DE (1) DE4006269A1 (fi)
FI (1) FI910973A (fi)
PT (1) PT96910A (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106271A (en) * 1992-09-03 2008-03-20 Yeda Res & Dev Ligand to TNF 75P receptor and its preparation
CA2107340C (en) * 1991-06-19 2003-06-10 Gunther Adolf Monoclonal antibodies against human tnf-binding protein i (tnf-bp i)
IL101769A (en) 1992-05-03 2007-02-11 Yeda Res & Dev Modulation of TNF receptor action
US6270766B1 (en) 1992-10-08 2001-08-07 The Kennedy Institute Of Rheumatology Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
IT1270943B (it) * 1993-05-14 1997-05-26 Mini Ricerca Scient Tecnolog Anticorpi monoclonali anti-recettore di tipo i tnf alfa, procedimento per la produzione e loro usi
US6620382B1 (en) 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
US8197430B1 (en) * 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
JP2004536786A (ja) * 2001-03-02 2004-12-09 メディミューン，インコーポレイテッド インテグリンαｖβ３拮抗薬を他の予防薬もしくは治療薬と組み合わせて投与することによる炎症性疾患または自己免疫疾患の予防または治療方法
JP2005535572A (ja) * 2002-04-12 2005-11-24 メディミューン，インコーポレーテッド 組換え抗インターロイキン−９抗体
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
WO2004012673A2 (en) * 2002-08-01 2004-02-12 Wyeth, Methods and reagents relating to inflammation and apoptosis
EP2316487B1 (en) 2003-04-11 2014-06-11 MedImmune, LLC Recombinant IL-9 antibodies & uses thereof
PL1949915T3 (pl) * 2004-04-30 2013-04-30 Biopheresis Tech Inc Sposób i układ do usuwania rozpuszczalnych TNFR1, TNFR2 i IL2R u pacjentów
US7351739B2 (en) * 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
US20060121042A1 (en) 2004-10-27 2006-06-08 Medimmune, Inc. Modulation of antibody specificity by tailoring the affinity to cognate antigens
GB0506708D0 (en) * 2005-04-01 2005-05-11 Queen Mary & Westfield College Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions
WO2008008373A2 (en) 2006-07-11 2008-01-17 Arubor Corp Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
DK2068889T3 (da) 2006-08-10 2020-02-03 Roy C Levitt Anakinra til anvendelse i behandling af bronchiolitis obliterans syndrom
ATE514714T1 (de) * 2007-03-19 2011-07-15 Univ Stuttgart Hutnfr1-selektive antagonisten
CN101861168B (zh) 2007-05-07 2014-07-02 米迪缪尼有限公司 抗-icos抗体及其在治疗肿瘤、移植和自身免疫病中的应用
CA2743469C (en) 2008-11-12 2019-01-15 Medimmune, Llc Antibody formulation
ES2618586T3 (es) 2010-09-16 2017-06-21 Baliopharm Ag Anticuerpo anti-huTNFR1
US11028178B2 (en) 2017-11-27 2021-06-08 Baliopharma Ag Method of treating nonalcoholic steatohepatitis by administering an antagonist human tumor necrosis factor receptor 1 (HUTNFR1) antibody

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4770995A (en) * 1985-08-29 1988-09-13 New York Blood Center, Inc Detection of the sensitivity of cells to the effects of tumor necrosis factor and lymphotoxin
EP0230574A3 (en) * 1986-01-31 1989-03-22 Yale University Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof
GB8806339D0 (en) * 1988-03-17 1988-04-13 Hoffmann La Roche Monoclonal antibodies

Also Published As

Publication number Publication date
PT96910A (pt) 1991-10-31
DE4006269A1 (de) 1991-08-29
US5736138A (en) 1998-04-07
FI910973A (fi) 1991-08-29
JPH04211392A (ja) 1992-08-03
EP0444560A1 (de) 1991-09-04

Similar Documents

Publication Publication Date Title
FI910973A0 (fi) Antikropp mot tumornekrosfaktorreseptor.
DE69112037D1 (de) Waferträger.
DE69112998D1 (de) Verbinder.
DE69111876D1 (de) Ophthalmometer.
DE59104521D1 (de) Polkern.
NO913529D0 (no) Forbandtprofil.
DE69101380D1 (de) Verbinder.
DE69103957D1 (de) Durchdringendes Geschoss.
FI895287A0 (fi) Monoklonal antikropp mot fukosylkeramid.
DE69100071D1 (de) Kaefigmutter.
FI914333A (fi) Varukaerra.
DE69108444D1 (de) Verbinder.
FI923486A0 (fi) Terapeutiska aemnen.
ATE124392T1 (de) 8-sulfamylmethylen-2-aminotetraline.
DE59103418D1 (de) Rückenlehne.
FI911599A (fi) Pinnisolatorkoppling.
DE59103525D1 (de) Honmachine.
DE69101006D1 (de) Photoelektrographische elemente.
FI910753A0 (fi) Terapeutiska nukleocider.
FI923528A (fi) Terapeutiska aemnen.
DE59100113D1 (de) Rollcontainer.
DE69104797D1 (de) 2-Substituierte-1-Hydroxyindole.
FI906461A0 (fi) Avskaerare.
NO911833D0 (no) Gulvsluk.
FI904178A (fi) Gelformula mot svamp.

Legal Events

Date Code Title Description
FD Application lapsed